Skip to main content

Table 1 Baseline characteristics of study sample (n = 40)

From: Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics

Sociodemograpic  
Age, mean (sd) 48 (6.4)
Gender, n (%)  
   Male 22 (55)
   Female 18 (45)
Race, n (%)a  
   White 15 (39)
   Black 6 (15)
   Other 18 (46)
Ethnicity, n (%)a  
   Hispanic 30 (77)
   Non-Hispanic 9 (23)
Education, n (%)  
   Grade 12/GED or lower 37 (93)
   College (partial or completed) 3 (7)
Marriage Status, n (%)  
   Married/living with partner 20 (50)
   Widowed/separated/divorced/single 20 (50)
Employed, n (%)a  
   Employed 4 (11)
   Unable to work/unemployed/other 34 (89)
Housing status, n (%)a  
   Stable 31 (82)
   Unstable 7 (18)
Psychiatric  
Psychiatric illness, n (%)b  
   Current psychiatric illness 26 (65)
   No current psychiatric illness 14 (35)
Depression: Beck Depression Inventory-II, n (%)  
   BDI 0-19 (none, minimal or mild) 19 (48)
   BDI 20-28 (moderate) 5 (12)
   BDI 29-63 (severe) 16 (40)
Drug and Alcohol Use  
Alcohol (by AUDIT), n (%)  
   At risk alcohol (AUDIT ≥ 8) 3 (8)
   Not at risk alcohol (AUDIT < 8) 37 (92)
Self-reported illicit drug use - past 30 days, n (%)  
   Cocaine/crack within 30 days 9 (23)
   Heroin within 30 days 9 (23)
   Any heroin/cocaine/crack within 30 days 15 (38)
Years of methadone maintenance, median (IQR) 10 (5 - 18)
Median methadone dose - mg, median (IQR) 90 (60 - 140)
HCV-related Factors  
HCV genotype, n (%)  
   Genotype 1 or 4 24 (60)
   Genotype 2 9 (23)
   Genotype 3 7 (17)
HCV Viral Load (IU/ml), n (%)  
   ≥ 800,000 IU/ml 15 (38)
   < 800,000 IU/ml 25 (62)
HIV status, n (%)  
   HIV- 29 (73)
   HIV+ 11 (27)
CD4 (cells/mm3), median (IQR) 476 (356 - 820)
Taking HAART, n (%) 7 (64)
  1. a missing data
  2. b depression, anxiety disorder, psychotic disorder, post-traumatic stress disorder, and/or bipolar disorder